跳至主要内容
临床试验/NCT02828150
NCT02828150已完成不适用

Integrative Parenteral Nutrition in Hospitalized, Malnourished, Hypophagic Cancer Patients With Contraindication to Enteral Nutrition

Fondazione IRCCS Policlinico San Matteo di Pavia2 个研究点 分布在 1 个国家目标入组 131 人开始时间: 2016年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
131
试验地点
2
主要终点
Phase angle

研究概览

简要总结

Although it is demonstrated that nutritional support can improve clinical outcomes, the literature shows that approximately 50% of cancer patients are not able to meet their estimated energy requirements. Recent clinical studies suggest that a supplementary support for parenteral nutrition (PN) could significantly help to improve the nutritional status of malnourished cancer patients.

International guidelines recommend the use of PN in malnourished, hypophagic, non-surgical cancer patients if enteral nutrition is not feasible and in patients affected by severe iatrogenic gastrointestinal complications and in whom inadequate food intake is anticipated for more than 7 days. However, there are no studies on the effects of integrative PN in hospitalized, malnourished, hypophagic, non-surgical cancer patients.

Recent studies have reported on the validity of bioelectrical impedance vector analysis in monitoring the body composition of patients receiving nutritional support. Particularly, phase angle proved to be a superior prognostic marker than other nutritional screening tools.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of cancer (head-neck, lung, gastrointestinal, pancreas, biliary tract, haematology).
  • Nutritional Risk Screening 2002 score ≥
  • Expected duration of parenteral nutrition ≥7 days
  • Availability to planned measurements
  • Contraindication to enteral nutrition support
  • Written informed consent

排除标准

  • Age < 18 years
  • Ongoing artificial nutrition before hospitalization
  • Eastern Cooperative Oncology Group performance status >2

研究组 & 干预措施

Parenteral nutrition

Experimental

Patients will receive a tailored nutritional support (parenteral nutrition) to cover estimated protein-calorie requirements

干预措施: Parenteral nutrition (Dietary Supplement)

结局指标

主要结局

Phase angle

时间窗: 7 days

Change in phase angle (a specific body composition parameter assessed by bioelectrical impedance vector analysis) after 7 days of nutritional support

次要结局

  • body weight(7 days)
  • body mass index(7 days)
  • Number of participants with treatment-related adverse events as assessed by biochemistry(7 days)
  • Handgrip strength(7 days)

研究者

发起方
Fondazione IRCCS Policlinico San Matteo di Pavia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Riccardo Caccialanza

Principal Investigator

Fondazione IRCCS Policlinico San Matteo di Pavia

研究点 (2)

Loading locations...

相似试验